Literature DB >> 27384751

Yield of Staging Laparoscopy and Lavage Cytology for Radiologically Occult Peritoneal Carcinomatosis of Gastric Cancer.

Naruhiko Ikoma1, Mariela Blum2, Yi-Ju Chiang1, Jeannelyn S Estrella3, Sinchita Roy-Chowdhuri3, Keith Fournier1, Paul Mansfield1, Jaffer A Ajani2, Brian D Badgwell4.   

Abstract

BACKGROUND: This study aimed to identify the yield of staging laparoscopy with peritoneal lavage cytology for gastric cancer patients and to track it over time.
METHODS: The medical records of patients with gastric or gastroesophageal adenocarcinoma who underwent pretreatment staging laparoscopy at the authors' institution from 1995 to 2012 were reviewed. The yield of laparoscopy was defined as the proportion of patients who had positive findings on laparoscopy, including those with macroscopic carcinomatosis, positive cytology, or other clinically important findings. To compare the yield of laparoscopy over time, the patients were divided into three 6-year ranges based on the date of diagnosis. Associations between clinicopathologic factors and peritoneal disease were examined using uni- and multivariate analyses.
RESULTS: The study included 711 patients. Among these patients, 43.5 % had gastroesophageal junction tumors, 72.9 % had poorly differentiated adenocarcinoma, and 53 % had signet ring cell morphology. Endoscopic ultrasound had most commonly identified T3 (83.9 %) and N-positive (66.4 %) tumors. At laparoscopy, 148 (20.8 %) patients had been found to have macroscopic peritoneal carcinomatosis. Among 514 macroscopically negative patients who underwent peritoneal lavage cytologic analysis, 68 (13.2 %) had positive cytology results for malignancy. The total laparoscopy yield was 36 %, which did not change over time (p = 0.58). Multivariate analysis demonstrated that positive cytology or carcinomatosis was associated with poorly differentiated histology, linitis plastica, and equivocal computed tomography findings.
CONCLUSIONS: Laparoscopy remains a useful staging procedure to evaluate for peritoneal spread when treatment or surgery is considered, even with the current availability of high-quality imaging.

Entities:  

Mesh:

Year:  2016        PMID: 27384751     DOI: 10.1245/s10434-016-5409-7

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  26 in total

1.  Risk of peritoneal metastases in patients who had negative peritoneal staging and received therapy for localized gastric adenocarcinoma.

Authors:  Dilsa Mizrak Kaya; Graciela M Nogueras-González; Kazuto Harada; Fatemeh G Amlashi; Sinchita Roy-Chowdhuri; Jeannelyn S Estrella; Prajnan Das; Jeffrey H Lee; Brian Weston; Manoop S Bhutani; Aurelio Matamoros; Irene Thomas; Quan Lin; Brian D Badgwell; Jaffer A Ajani
Journal:  J Surg Oncol       Date:  2017-12-04       Impact factor: 3.454

Review 2.  Heated intraperitoneal chemotherapy and gastrectomy for gastric cancer in the U.S.: the time is now.

Authors:  Zachary J Brown; Jonathan M Hernandez; R Taylor Ripley; Jeremy L Davis
Journal:  J Gastrointest Oncol       Date:  2017-12

3.  Staging Laparoscopy is Underutilized in the Management of Gastric Adenocarcinoma.

Authors:  Eric M Groh; Shreya Gupta; Zachary J Brown; Lindsey Enewold; Lauren A Gamble; Jonathan M Hernandez; Jeremy L Davis
Journal:  Ann Surg Oncol       Date:  2019-11-20       Impact factor: 5.344

4.  Repeat staging laparoscopy for gastric cancer after preoperative therapy.

Authors:  Cornelius A Thiels; Naruhiko Ikoma; Keith Fournier; Prajnan Das; Mariela Blum; Jeannelyn S Estrella; Bruce D Minsky; Jaffer Ajani; Paul Mansfield; Brian D Badgwell
Journal:  J Surg Oncol       Date:  2018-06-07       Impact factor: 3.454

5.  Evaluation of the American Joint Committee on Cancer 8th edition staging system for gastric cancer patients after preoperative therapy.

Authors:  Naruhiko Ikoma; Mariela Blum; Jeannelyn S Estrella; Prajnan Das; Wayne L Hofstetter; Keith F Fournier; Paul Mansfield; Jaffer A Ajani; Brian D Badgwell
Journal:  Gastric Cancer       Date:  2017-06-22       Impact factor: 7.370

6.  A Bounding Box-Based Radiomics Model for Detecting Occult Peritoneal Metastasis in Advanced Gastric Cancer: A Multicenter Study.

Authors:  Dan Liu; Weihan Zhang; Fubi Hu; Pengxin Yu; Xiao Zhang; Hongkun Yin; Lanqing Yang; Xin Fang; Bin Song; Bing Wu; Jiankun Hu; Zixing Huang
Journal:  Front Oncol       Date:  2021-12-03       Impact factor: 6.244

Review 7.  Indication of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer (Gastripec, Gastrichip).

Authors:  Beate Rau; Linda Feldbrügge; Felix Gronau; Miguel Enrique Alberto Vilchez; Peter Thuss-Patience; Pierre Emmanuel Bonnot; Olivier Glehen
Journal:  Visc Med       Date:  2022-02-23

8.  Phase I Trial of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) with Cisplatin, Mitomycin, and Paclitaxel in Patients with Gastric Adenocarcinoma and Associated Carcinomatosis or Positive Cytology.

Authors:  Mariela Blum Murphy; Naruhiko Ikoma; Xuemei Wang; Jeannelyn Estrella; Sinchita Roy-Chowdhuri; Prajnan Das; Bruce D Minsky; Shumei Song; Paul Mansfield; Jaffer Ajani; Brian Badgwell
Journal:  Ann Surg Oncol       Date:  2020-01-23       Impact factor: 5.344

Review 9.  [Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer].

Authors:  Felix Gronau; Maximilian Jara; Linda Feldbrügge; Vincent Wolf; Alan Oeff; Beate Rau
Journal:  Chirurg       Date:  2021-02-23       Impact factor: 0.955

10.  Comparison of laparoscopy versus mini-laparotomy for jejunostomy placement in patients with gastric adenocarcinoma.

Authors:  Catherine H Davis; Naruhiko Ikoma; Paul F Mansfield; Prajnan Das; Bruce D Minsky; Mariela A Blum; Jaffer A Ajani; Barbara L Bass; Brian D Badgwell
Journal:  Surg Endosc       Date:  2020-11-10       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.